NasdaqGS - Nasdaq Real Time Price USD
Sarepta Therapeutics, Inc. (SRPT)
As of 9:35 AM EST. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 110,376 | 9 |
| Sales | 56,699 | 3 |
| Net Shares Purchased (Sold) | 53,677 | 12 |
| Total Insider Shares Held | 4.18M | -- |
| % Net Shares Purchased (Sold) | 1.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| CONNELLY DEIRDRE P Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 12, 2024 |
| BEHRENS M KATHLEEN Director | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 4, 2024 |
| ESTEPAN IAN MICHAEL Chief Financial Officer | Sale at price 137.36 per share. | Direct | 822,100 | Aug 30, 2024 |
| CHAMBERS MICHAEL ANDREW Director | Purchase at price 133.07 - 134.66 per share. | Indirect | 4,955,728 | Aug 16, 2024 |
| BEHRENS M KATHLEEN Director | Conversion of Exercise of derivative security at price 13.90 per share. | Direct | 208,500 | Jul 3, 2024 |
| BROWN RYAN EDWARD General Counsel | Sale at price 158.07 - 164.52 per share. | Direct | 6,296,029 | Jun 25, 2024 |
| ARIF BILAL Chief Technology Officer | Sale at price 162.31 - 167.13 per share. | Direct | 1,917,891 | Jun 25, 2024 |
| BROWN RYAN EDWARD General Counsel | Conversion of Exercise of derivative security at price 62.77 per share. | Direct | 1,475,095 | Jun 25, 2024 |
| RODINO-KLAPAC LOUISE Officer | -- | Direct | -- | Jun 21, 2024 |
| ESTEPAN IAN MICHAEL Chief Financial Officer | -- | Direct | -- | Jun 21, 2024 |
| ARIF BILAL Chief Technology Officer | -- | Direct | -- | Jun 21, 2024 |
| MURRAY DALLAN Officer | -- | Direct | -- | Jun 21, 2024 |
| MURRAY DALLAN Officer | Sale at price 140.00 per share. | Direct | 508,900 | May 2, 2024 |
| BOOR KATHRYN JEAN Director | Sale at price 122.93 per share. | Direct | 93,550 | Mar 11, 2024 |
| WIGZELL HANS LENNART RUDOLF Director | Sale at price 122.39 - 123.85 per share. | Direct | 1,848,795 | Mar 8, 2024 |
| WIGZELL HANS LENNART RUDOLF Director | Conversion of Exercise of derivative security at price 13.90 per share. | Direct | 208,500 | Mar 8, 2024 |
| MAYO STEPHEN L. Director | Sale at price 122.96 per share. | Direct | 385,480 | Mar 5, 2024 |
| BEHRENS M KATHLEEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| NICAISE CLAUDE M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| BOOR KATHRYN JEAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| RODINO-KLAPAC LOUISE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| ESTEPAN IAN MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| BROWN RYAN EDWARD General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| MAYO STEPHEN L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| CHAMBERS MICHAEL ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| ARIF BILAL Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| BARRY RICHARD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| WIGZELL HANS LENNART RUDOLF Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 1, 2024 |
| ESTEPAN IAN MICHAEL Chief Financial Officer | Sale at price 128.30 per share. | Direct | 153,960 | Mar 1, 2024 |
| BROWN RYAN EDWARD General Counsel | Sale at price 125.34 per share. | Direct | 250,680 | Mar 1, 2024 |
| ARIF BILAL Chief Technology Officer | Sale at price 128.58 - 129.71 per share. | Direct | 257,676 | Mar 1, 2024 |
| WIGZELL HANS LENNART RUDOLF Director | Conversion of Exercise of derivative security at price 128.67 per share. | Direct | 473,377 | Mar 1, 2024 |
| INGRAM DOUGLAS S Chief Executive Officer | Purchase at price 78.57 - 81.26 per share. | Direct | 2,001,800 | Nov 3, 2023 |
| BARRY RICHARD J Director | Purchase at price 78.81 per share. | Indirect | 3,940,500 | Nov 3, 2023 |
| BEHRENS M KATHLEEN Director | Conversion of Exercise of derivative security at price 29.03 per share. | Direct | 435,450 | Nov 3, 2023 |
| CHAMBERS MICHAEL ANDREW Director | Purchase at price 109.19 - 109.89 per share. | Indirect | 1,092,429 | Aug 14, 2023 |
| CHAMBERS MICHAEL ANDREW Director | Purchase at price 108.05 per share. | Indirect | 2,559,272 | Aug 11, 2023 |
| CHAMBERS MICHAEL ANDREW Director | Purchase at price 104.67 - 106.26 per share. | Indirect | 3,701,067 | Aug 10, 2023 |
| WIGZELL HANS LENNART RUDOLF Director | Sale at price 106.72 per share. | Direct | 1,600,800 | Aug 4, 2023 |
| WIGZELL HANS LENNART RUDOLF Director | Conversion of Exercise of derivative security at price 29.03 per share. | Direct | 435,450 | Aug 4, 2023 |
| BEHRENS M KATHLEEN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| NICAISE CLAUDE M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| BOOR KATHRYN JEAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| RODINO-KLAPAC LOUISE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| ESTEPAN IAN MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| BROWN RYAN EDWARD General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| MAYO STEPHEN L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| CHAMBERS MICHAEL ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| ARIF BILAL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
| BARRY RICHARD J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 6, 2023 |
Related Tickers
APLS Apellis Pharmaceuticals, Inc.
28.57
-0.90%
ALNY Alnylam Pharmaceuticals, Inc.
275.07
+0.75%
MDGL Madrigal Pharmaceuticals, Inc.
342.38
+1.23%
ACAD ACADIA Pharmaceuticals Inc.
16.42
+3.99%
TGTX TG Therapeutics, Inc.
27.06
-0.40%
KRYS Krystal Biotech, Inc.
182.26
-0.45%
VRNA Verona Pharma plc
37.28
-0.82%
BEAM Beam Therapeutics Inc.
26.85
+0.85%
ARGX argenx SE
589.60
+0.11%
CYTK Cytokinetics, Incorporated
55.46
-0.07%